Una colaboración farmacéutico-médico para el cuidado de diabetes

El programa de la iniciativa de diabetes

Translated title of the contribution: Pharmacist-physician collaboration for diabetes care: The diabetes initiative program

Michelle Zingone Farland, Debbie C. Byrd, M. Shawn McFarland, Jeremy Thomas, Andrea Franks, Christa George, Benjamin N. Gross, Alexander B. Guirguis, Katie J. Suda

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

BACKGROUND: Multiple complications can arise secondary to poor control of glucose, blood pressure, and cholesterol in a patient with diabetes. OBJECTIVE: To evaluate the effect of a pharmacist-physician collaboration on attainment of diabetes-related measures of control. METHODS: This was a prospective, multicenter, cohort study. Patients were enrolled from 7 practice sites throughout Tennessee if they had been diagnosed with type 2 diabetes, were aged 18 years or older with a life expectancy greater than 1 year, and were English speaking. Pregnant women were excluded. Patients were followed for 12 months following enrollment by informed consent. The pharmacist-physician collaboration method was established prior to study initiation. Primary outcomes included hemoglobin A1c (A1C), number of patients with A1C less than 7%, and percentage of patients with A1C greater than 9%. RESULTS: Of the 206 patients enrolled, the mean age was 59.73 years, and most were male (59.71%) and white (66.02%). The A1C was reduced by an average of 1.16% (p < 0.0001). The proportion of patients with A1C less than 7% increased from 12.75% at baseline to 36.76% at study conclusion (p = 0.0002). The proportion of patients with A1C greater than 9% decreased from 34.15% to 16.50%, (p < 0.0001). CONCLUSIONS: Pharmacist-physician collaborative management at multiple practice locations and types of setting (eg, private, academic, Veterans Affairs medical center) has a positive impact on glycemic control and diabetes-related health maintenance. This was accomplished without increasing the total number of antihyper-glycemic agents prescribed and without an increase in patient-reported episodes of hypo glycemia.

Original languageSpanish
Pages (from-to)781-789
Number of pages9
JournalAnnals of Pharmacotherapy
Volume47
Issue number6
DOIs
StatePublished - Jun 1 2013

Fingerprint

Pharmacists
Physicians
Veterans
Life Expectancy
Informed Consent
Type 2 Diabetes Mellitus
Multicenter Studies
Pregnant Women
Hemoglobins
Cohort Studies
Cholesterol
Blood Pressure
Glucose
Health

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Cite this

Una colaboración farmacéutico-médico para el cuidado de diabetes : El programa de la iniciativa de diabetes. / Farland, Michelle Zingone; Byrd, Debbie C.; Shawn McFarland, M.; Thomas, Jeremy; Franks, Andrea; George, Christa; Gross, Benjamin N.; Guirguis, Alexander B.; Suda, Katie J.

In: Annals of Pharmacotherapy, Vol. 47, No. 6, 01.06.2013, p. 781-789.

Research output: Contribution to journalArticle

Farland, MZ, Byrd, DC, Shawn McFarland, M, Thomas, J, Franks, A, George, C, Gross, BN, Guirguis, AB & Suda, KJ 2013, 'Una colaboración farmacéutico-médico para el cuidado de diabetes: El programa de la iniciativa de diabetes', Annals of Pharmacotherapy, vol. 47, no. 6, pp. 781-789. https://doi.org/10.1345/aph.1S079
Farland, Michelle Zingone ; Byrd, Debbie C. ; Shawn McFarland, M. ; Thomas, Jeremy ; Franks, Andrea ; George, Christa ; Gross, Benjamin N. ; Guirguis, Alexander B. ; Suda, Katie J. / Una colaboración farmacéutico-médico para el cuidado de diabetes : El programa de la iniciativa de diabetes. In: Annals of Pharmacotherapy. 2013 ; Vol. 47, No. 6. pp. 781-789.
@article{ce6a822552fe44639a937c03ace35a47,
title = "Una colaboraci{\'o}n farmac{\'e}utico-m{\'e}dico para el cuidado de diabetes: El programa de la iniciativa de diabetes",
abstract = "BACKGROUND: Multiple complications can arise secondary to poor control of glucose, blood pressure, and cholesterol in a patient with diabetes. OBJECTIVE: To evaluate the effect of a pharmacist-physician collaboration on attainment of diabetes-related measures of control. METHODS: This was a prospective, multicenter, cohort study. Patients were enrolled from 7 practice sites throughout Tennessee if they had been diagnosed with type 2 diabetes, were aged 18 years or older with a life expectancy greater than 1 year, and were English speaking. Pregnant women were excluded. Patients were followed for 12 months following enrollment by informed consent. The pharmacist-physician collaboration method was established prior to study initiation. Primary outcomes included hemoglobin A1c (A1C), number of patients with A1C less than 7{\%}, and percentage of patients with A1C greater than 9{\%}. RESULTS: Of the 206 patients enrolled, the mean age was 59.73 years, and most were male (59.71{\%}) and white (66.02{\%}). The A1C was reduced by an average of 1.16{\%} (p < 0.0001). The proportion of patients with A1C less than 7{\%} increased from 12.75{\%} at baseline to 36.76{\%} at study conclusion (p = 0.0002). The proportion of patients with A1C greater than 9{\%} decreased from 34.15{\%} to 16.50{\%}, (p < 0.0001). CONCLUSIONS: Pharmacist-physician collaborative management at multiple practice locations and types of setting (eg, private, academic, Veterans Affairs medical center) has a positive impact on glycemic control and diabetes-related health maintenance. This was accomplished without increasing the total number of antihyper-glycemic agents prescribed and without an increase in patient-reported episodes of hypo glycemia.",
author = "Farland, {Michelle Zingone} and Byrd, {Debbie C.} and {Shawn McFarland}, M. and Jeremy Thomas and Andrea Franks and Christa George and Gross, {Benjamin N.} and Guirguis, {Alexander B.} and Suda, {Katie J.}",
year = "2013",
month = "6",
day = "1",
doi = "10.1345/aph.1S079",
language = "Spanish",
volume = "47",
pages = "781--789",
journal = "Annals of Pharmacotherapy",
issn = "1060-0280",
publisher = "Harvey Whitney Books Company",
number = "6",

}

TY - JOUR

T1 - Una colaboración farmacéutico-médico para el cuidado de diabetes

T2 - El programa de la iniciativa de diabetes

AU - Farland, Michelle Zingone

AU - Byrd, Debbie C.

AU - Shawn McFarland, M.

AU - Thomas, Jeremy

AU - Franks, Andrea

AU - George, Christa

AU - Gross, Benjamin N.

AU - Guirguis, Alexander B.

AU - Suda, Katie J.

PY - 2013/6/1

Y1 - 2013/6/1

N2 - BACKGROUND: Multiple complications can arise secondary to poor control of glucose, blood pressure, and cholesterol in a patient with diabetes. OBJECTIVE: To evaluate the effect of a pharmacist-physician collaboration on attainment of diabetes-related measures of control. METHODS: This was a prospective, multicenter, cohort study. Patients were enrolled from 7 practice sites throughout Tennessee if they had been diagnosed with type 2 diabetes, were aged 18 years or older with a life expectancy greater than 1 year, and were English speaking. Pregnant women were excluded. Patients were followed for 12 months following enrollment by informed consent. The pharmacist-physician collaboration method was established prior to study initiation. Primary outcomes included hemoglobin A1c (A1C), number of patients with A1C less than 7%, and percentage of patients with A1C greater than 9%. RESULTS: Of the 206 patients enrolled, the mean age was 59.73 years, and most were male (59.71%) and white (66.02%). The A1C was reduced by an average of 1.16% (p < 0.0001). The proportion of patients with A1C less than 7% increased from 12.75% at baseline to 36.76% at study conclusion (p = 0.0002). The proportion of patients with A1C greater than 9% decreased from 34.15% to 16.50%, (p < 0.0001). CONCLUSIONS: Pharmacist-physician collaborative management at multiple practice locations and types of setting (eg, private, academic, Veterans Affairs medical center) has a positive impact on glycemic control and diabetes-related health maintenance. This was accomplished without increasing the total number of antihyper-glycemic agents prescribed and without an increase in patient-reported episodes of hypo glycemia.

AB - BACKGROUND: Multiple complications can arise secondary to poor control of glucose, blood pressure, and cholesterol in a patient with diabetes. OBJECTIVE: To evaluate the effect of a pharmacist-physician collaboration on attainment of diabetes-related measures of control. METHODS: This was a prospective, multicenter, cohort study. Patients were enrolled from 7 practice sites throughout Tennessee if they had been diagnosed with type 2 diabetes, were aged 18 years or older with a life expectancy greater than 1 year, and were English speaking. Pregnant women were excluded. Patients were followed for 12 months following enrollment by informed consent. The pharmacist-physician collaboration method was established prior to study initiation. Primary outcomes included hemoglobin A1c (A1C), number of patients with A1C less than 7%, and percentage of patients with A1C greater than 9%. RESULTS: Of the 206 patients enrolled, the mean age was 59.73 years, and most were male (59.71%) and white (66.02%). The A1C was reduced by an average of 1.16% (p < 0.0001). The proportion of patients with A1C less than 7% increased from 12.75% at baseline to 36.76% at study conclusion (p = 0.0002). The proportion of patients with A1C greater than 9% decreased from 34.15% to 16.50%, (p < 0.0001). CONCLUSIONS: Pharmacist-physician collaborative management at multiple practice locations and types of setting (eg, private, academic, Veterans Affairs medical center) has a positive impact on glycemic control and diabetes-related health maintenance. This was accomplished without increasing the total number of antihyper-glycemic agents prescribed and without an increase in patient-reported episodes of hypo glycemia.

UR - http://www.scopus.com/inward/record.url?scp=84878504879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878504879&partnerID=8YFLogxK

U2 - 10.1345/aph.1S079

DO - 10.1345/aph.1S079

M3 - Article

VL - 47

SP - 781

EP - 789

JO - Annals of Pharmacotherapy

JF - Annals of Pharmacotherapy

SN - 1060-0280

IS - 6

ER -